RxSight Inc (NAS:RXST)
$ 56.45 2.12 (3.9%) Market Cap: 2.24 Bil Enterprise Value: 2.02 Bil PE Ratio: 0 PB Ratio: 8.13 GF Score: 58/100

Q4 2022 Rxsight Inc Earnings Call Transcript

Mar 06, 2023 / 09:30PM GMT
Release Date Price: $15.69 (+12.96%)
Operator

Good day and thank you for standing by. Welcome to the RxSight Fourth Quarter Earnings Conference Call. (Operator Instructions) Please be advised that today's conference call is being recorded.

I would now like to propound the conference over to your speaker today, Alex Huang, Investor Relations. Please go ahead.

Alex Huang
RxSight, Inc. - IR

Thank you, operator. Presenting today are RxSight President and Chief Executive Officer, Ron Kurtz and the Chief Financial Officer, Shelley Thunen. Earlier today, RxSight released financial results for the 3 months and fiscal year ended December 31, 2022. A copy of the press release is available on the company's website.

Before we begin, I would like to inform you that the comments and responses to your questions during today's call, reflect management's views as of today, March 6, 2023 and will include forward-looking statements and opinion statements, including predictions, estimates, plans, expectations and other information. Actual results may differ materially from those expressed or implied as a

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot